bioAffinity Technologies, Inc. Prepaid Insurance
bioAffinity Technologies, Inc. (BIAF) had Prepaid Insurance of $137.15 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidInsurance · last filed 2026-08-07
- 2026-06-30: Prepaid Insurance $137.15K.
- 2026-03-31: Prepaid Insurance $175.18K.
- 2025-12-31: Prepaid Insurance $227.95K.
- 2025-09-30: Prepaid Insurance $224.21K.
| Period end | Prepaid Insurance |
|---|---|
| 2026-06-30 | $137.15K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $175.18K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $227.95K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $224.21K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $141.18K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $160.76K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $248.36K 10-K · filed 2026-03-16 |
| 2024-09-30 | $275.71K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $77.43K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $120.22K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $171.85K 10-K · filed 2025-03-31 |
| 2023-09-30 | $240.54K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $104.29K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $222.74K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $340.08K 10-K · filed 2024-04-01 |
| 2022-09-30 | $471.27K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $16.77K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |